CSF biomarker profiles do not differentiate between the cerebellar and parkinsonian phenotypes of multiple system atrophy
- PMID: 17448720
- DOI: 10.1016/j.parkreldis.2007.02.002
CSF biomarker profiles do not differentiate between the cerebellar and parkinsonian phenotypes of multiple system atrophy
Abstract
Background: Multiple system atrophy (MSA) can clinically be divided into the cerebellar (MSA-C) and the parkinsonian (MSA-P) variants. It is unknown whether the variation in clinical expression is also reflected by a different underlying neurochemical profile.
Methods: We analyzed brain specific proteins and neurotransmitter metabolites in cerebrospinal fluid (CSF) of 26 patients with MSA-C and 19 with MSA-P.
Results: No differences were found between MSA-C and MSA-P.
Conclusion: Our results suggest that the clinical and in part pathological distinction between the two clinical MSA phenotypes is not reflected by the neurochemical composition of CSF.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
